Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Up – Should You Buy?

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) shares gapped up before the market opened on Thursday . The stock had previously closed at $10.75, but opened at $11.26. Shionogi & Co., Ltd. Unsponsored ADR shares last traded at $10.78, with a volume of 7,347 shares trading hands.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

The company has a current ratio of 5.84, a quick ratio of 5.21 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $18.27 billion, a P/E ratio of 14.13, a price-to-earnings-growth ratio of 1.02 and a beta of 0.17. The stock has a 50 day moving average of $10.72 and a 200-day moving average of $9.36.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.19 by $0.09. The company had revenue of $966.53 million during the quarter, compared to analysts’ expectations of $848.42 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.70% and a net margin of 41.82%. On average, equities research analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.